Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/25/2007US20070249642 Azabicyclo[3.1.0]hex-3-yl}alkyl)pyrimidinedione
10/25/2007US20070249641 Adenosine a3 receptor modulators
10/25/2007US20070249640 Pharmaceutical compositions and use thereof
10/25/2007US20070249639 Use of 9H-Purine-2,6-Diamine Derivatives in the Treatment of Proliferative Diseases and Novel 9H-Purine-2,6-Diamine Derivatives
10/25/2007US20070249638 Derivatives of triazoly-imidazopyridine and of the triazolypurines useful as ligands of the adenosine A2a receptor and their use as medicaments
10/25/2007US20070249637 Inhibitors Of Hepatitis C Virus Protease, And Compositions And Treatments Using The Same
10/25/2007US20070249636 Selected Fused Heterocyclics and Uses Thereof
10/25/2007US20070249635 Fungicidal Mixtures Based on a Triazolopyrimidine Derivative and a Conazole
10/25/2007US20070249632 Pharmaceutical compositions and use thereof
10/25/2007US20070249630 Phenethanolamine derivatives for treatment of respiratory diseases
10/25/2007US20070249629 Viral Polymerase Inhibitors
10/25/2007US20070249628 Use of Mast Cells Inhibitors for Treating Patients Exposed to Chemical or Biological Weapons
10/25/2007US20070249627 Tubulin inhibitor and process for its preparation
10/25/2007US20070249626 Diaza heterocyclic amide compounds and their uses
10/25/2007US20070249625 Il-8 Receptor Antagonists
10/25/2007US20070249624 4-squarylpiperazine derivatives such as 3-(1-Piperazinyl)-4-(2-thienyl)-cyclobut-2-ene-1,2-dione with other an AIDS antiviral agent, antiinfective agent, an immunomodulator, and HIV entry inhibit; viricide; human immunodeficiency virus-1 (HIV) and acquired immunodeficiency syndrome (AIDS)
10/25/2007US20070249623 1-(Indole-6-Carbonyl-D-Phenylglycinyl)-4-(1-Methylpiperidin-4-Yl)Piperazine D-Tartrate
10/25/2007US20070249622 Nicotinic receptor agonists and analogues and derivatives thereof for the treatment of inflammatory diseases
10/25/2007US20070249621 Pharmacological treatment of parkinson's disease
10/25/2007US20070249620 Urea Derivative
10/25/2007US20070249619 Diarylmethyl Piperazine Derivatives, Preparations Thereof and Uses Thereof
10/25/2007US20070249618 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression
10/25/2007US20070249617 3-(6-p-Tolyl-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; treatment of psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerataive disorders such as senile dementia, Alzhelmer's disease and other intellectual impairment disorders
10/25/2007US20070249616 Substituted 1-Benzyl-4-Substituted Piperazine Analogues
10/25/2007US20070249615 Pyridine [3,4-b] Pyrazinones
10/25/2007US20070249614 Antagonists of the Vanilloid Receptor Subtype 1 (VR1) and Uses Thereof
10/25/2007US20070249613 Reduction of Toxicity of Multi-Targeting Antifolates
10/25/2007US20070249612 Substituted 2H-[1,2,4]Triazolo[4,3-A]Pyrazines as Gsk-3 Inhibitors
10/25/2007US20070249611 Dipeptidyl peptidase inhibitors
10/25/2007US20070249610 PROCESS FOR THE PREPARATION OF [(1R), 2S]-2-AMINOPROPIONIC ACID 2-[4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TRIAZIN-6-YLOXY]-1-METHYLETHYL ESTER
10/25/2007US20070249609 Benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
10/25/2007US20070249608 Inhibitors of c-fms kinase
10/25/2007US20070249607 Nk-1 and serotonin transporter inhibitors
10/25/2007US20070249606 2,4-dichloro-N-{[1- (isopropylsulfonyl)-4- (morpholine-4- ylcarbonyl)piperidin-4- yl]methyl}benzamide; selective GlyT1 uptake inhibitors; nervous system, psychological disorders; cognition activators; dementia; schizophrenia; Parkinson's/Alzheimer diseases;bipolar disorders; neuroleptic agents
10/25/2007US20070249605 such as methyl 2-(4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetate
10/25/2007US20070249604 3-Monosubstituted tropane derivatives as nociceptin receptor ligands
10/25/2007US20070249603 3-Arylsulfonyl-Quinolines as 5-Ht6 Receptor Antagonists for the Treatment of Cns Disorders
10/25/2007US20070249602 Abnormal Cannabidiols as agents for lowering intraocular pressure
10/25/2007US20070249601 Compounds and therapeutical use thereof
10/25/2007US20070249600 Chemical compounds
10/25/2007US20070249599 Novel Chemical Compounds
10/25/2007US20070249598 selective antagonists of A2B adenosine receptors; for improving insulin sensitivity; asthma
10/25/2007US20070249597 Pyrazoloquinolones are potent parp inhibitors
10/25/2007US20070249596 Abnormal cannabidiols as agents for lowering intraocular pressure
10/25/2007US20070249595 Novel Enantiomeric Pure Beta Agonists, Manufacturing and Use as a Medicament Thereof
10/25/2007US20070249594 Benzothiazine and benzothiadiazine compounds
10/25/2007US20070249593 e.g. 4-Cyano-1H-imidazole-2-carboxylic acid [2-cyclohex-1-enyl-4-(2,6-dioxo-piperidin-4-yl)-phenyl]-amide; tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent
10/25/2007US20070249592 Use of selected CGRP antagonists in treatment and prevention of hot flushes in prostate cancer patients
10/25/2007US20070249591 Biaryl Amino Acids and Their Use in Dna Binding Oligomers
10/25/2007US20070249590 Substituted indolo[2,3-a]pyrrolo[3,4-c]carbazole compounds useful in treating kinase disorders
10/25/2007US20070249589 Novel diazepan derivatives
10/25/2007US20070249588 Nicotinic Acetylcholine Receptor Ligands
10/25/2007US20070249587 Aromatic-Ring-Fused Pyrimidine Derivative
10/25/2007US20070249586 Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity
10/25/2007US20070249585 Triazolobenzodiazepines and Their Use as Vasopressin Antagonists
10/25/2007US20070249584 N-[(S)-1-(4-benzyl)-2-oxoperhydroazepin-3-yl]-(E)-(2R,3R,4S,5R)-3,4,5-trihydroxy-2-methoxy-8-methyldec-6-enamide; N-[(S)-1-(3-amino-1H-indazol-5-ylmethyl)-2-oxoperhydroazepin-3-yl]-(E)-(2R,3R,4S,5R)-3,4,5-trihydroxy-2-methoxy-8-methyldec-6-enamide;anticancer agents
10/25/2007US20070249583 Used on its own or in combination with a platelet aggregation inhibitor; cholesterol biosynthesis, modulating blood serum lipids, for example lowering LDL cholesterol and/or increasing HDL cholesterol, treating hyperlipidemia, dyslipidemia, hypercholesterolemia, hypertriglyceridemia and atherosclerosis
10/25/2007US20070249582 Method of Treating Substance Abuse with Quetiapine
10/25/2007US20070249581 Abnormal Cannabidiols as agents for lowering intraocular pressure
10/25/2007US20070249580 Novel Cyclic Amino Benzoic Acid Derivative
10/25/2007US20070249579 Diketo-piperazine and piperidine derivatives as antiviral agents
10/25/2007US20070249578 New amidino derivatives and their use as thrombin inhibitors
10/25/2007US20070249577 Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
10/25/2007US20070249576 Cefdinir Oral Suspension
10/25/2007US20070249575 Vascular endothelial receptor specific inhibitors
10/25/2007US20070249574 Stanol composition and the use thereof
10/25/2007US20070249573 17alpha-substituted 4-(3-oxoestra-4,9-dien-11beta-yl)-benzoic acid, its derivatives and process for its production
10/25/2007US20070249572 Systems and methods for the delivery of corticosteroids
10/25/2007US20070249571 Novel conjugate compounds and dermatological compositions thereof
10/25/2007US20070249570 Homogeneously formulating microdosed active principles
10/25/2007US20070249569 2-Methylene-19-nor-1alpha-hydroxy-17-ene-homopregnacalciferol and its uses
10/25/2007US20070249568 17,20(E)-dehydro vitamin D analogs and their uses
10/25/2007US20070249567 2-Methylene-19,26,27-Trinor-(20S)-1Alpha-Hydroxyvitamin D3 and Its Uses
10/25/2007US20070249566 Compositions and methods useful for treatment of respiratory illness
10/25/2007US20070249565 Class of Gamma Delta T Cells Activators and Use Thereof
10/25/2007US20070249564 Novel phosphorus-containing prodrugs
10/25/2007US20070249563 Reacting a 3-trichloromethyliminooxymethyl-5,5-diphenylhydantoin compound with dibenzyl phosphate, and hydrogenolysis of the benzyl ester
10/25/2007US20070249562 Treatment of atrial fibrillation
10/25/2007US20070249561 Pharmacological method for treatment of neuropathic pain
10/25/2007US20070249560 Hydrolysis resistant organomodified silyated surfactants
10/25/2007US20070249559 Hydrating Composition
10/25/2007US20070249558 System and Method for Promoting Coronary Angiogenesis
10/25/2007US20070249557 Compositions and methods for viscosupplementation
10/25/2007US20070249556 Method of treating inflammation
10/25/2007US20070249555 Use of Atp Analogues for Treatment of Cardiovascular Diseases
10/25/2007US20070249554 Methods for therapy of neurodegenerative disease of the brain
10/25/2007US20070249553 Vaccine And Nucleic Acids Capable Of Protecting Poultry Against Colonisation By Campylobacter
10/25/2007US20070249552 Compositions and Methods for Sirna Inhibition of Primate Polyomavirus Genes
10/25/2007US20070249551 Compositions and methods for non-parenteral delivery of oligonucleotides
10/25/2007US20070249549 Compounds and Methods for Rna Interference of the P65 Subunit of Nf-Kappa-B
10/25/2007US20070249548 Nucleoside Analog or Salts of the Same
10/25/2007US20070249547 a synergistic mixture of paclitaxel or docetaxel and 13-deoxydoxorubicin, 13-deoxydaunorubicin, 13-deoxycaminomycin, 13-deoxyepirubicin, 13-deoxyidarubicin, 13-deoxyannamycin, 13-deoxyamrubicin or 5-imino analogs, with reduced toxicity and side effects; combination therapy
10/25/2007US20070249546 Ophthalmic and related aqueous solutions containing antifungal agents, uses therefor and methods for preparing them
10/25/2007US20070249545 Dihydrofolate reductase inhibition by epigallocatechin gallate compounds
10/25/2007US20070249544 Crystalline form of 1-chloro-4-(beta-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
10/25/2007US20070249543 Dissolution of arterial cholesterol plaques by phytochemical emulsifiers
10/25/2007US20070249542 mixture of sophorolipids comprises Ethyl 17-L-[(2'-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)-oxy]-cis-9-octadecenoate or the -6',6''-diacetate; esters of the disaccharide sugar sophorose; saline and glucose, and heparinized sodium-citrate-citric acid-dextrose solution
10/25/2007US20070249541 Combined use of enzyme inhibitors and of pharmaceutical compositions thereof
10/25/2007US20070249538 tumor necrosis factor (TNF) antagonists and corresponding nucleic acids; inflammatory diseases; the proteins lack exon 7 and which can bind TNF and can act as a TNF antagonist
10/25/2007US20070249537 Absorption enhancing agents
1 ... 3530 3531 3532 3533 3534 3535 3536 3537 3538 3539 3540 3541 3542 3543 3544 3545 3546 3547 3548 3549 3550 ... 7860